Fonda has always just been the appetiser in my mind.
I am not sure what proportion of the SP Fonda is valued at, but HA-Irinotecan for mCRC sitting on the cusp of Phase III approval is surely valued at more than 63 cents given the potential return.
And if HA-I for mCRC is successful, then the whole platform becomes free-carried and I'd imagine deal opportunities for HA for SCLC and the earlier stage HA combos will start to come into play.
If this was a mining stock, or a Poker hand at the casino, it would already be going gangbusters on the odds of success. Its great that it isn't, because it still allows those in the know to average up as the market slowly wises up to things.
Not long now - GLTA.
- Forums
- ASX - By Stock
- TSN
- Alchemia’s make-or-break moment arrives with late-stage cancer drug
Alchemia’s make-or-break moment arrives with late-stage cancer drug, page-27
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable